These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15081792)

  • 1. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.
    Morley KC; Li KM; Hunt GE; Mallet PE; McGregor IS
    Neuropharmacology; 2004 Jun; 46(7):954-65. PubMed ID: 15081792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THC Prevents MDMA Neurotoxicity in Mice.
    Touriño C; Zimmer A; Valverde O
    PLoS One; 2010 Feb; 5(2):e9143. PubMed ID: 20174577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats.
    Lopez-Rodriguez AB; Llorente-Berzal A; Garcia-Segura LM; Viveros MP
    Br J Pharmacol; 2014 Mar; 171(6):1435-47. PubMed ID: 24236988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats.
    Shen EY; Ali SF; Meyer JS
    Neuropharmacology; 2011 Dec; 61(8):1183-92. PubMed ID: 21763331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.
    McGregor IS; Gurtman CG; Morley KC; Clemens KJ; Blokland A; Li KM; Cornish JL; Hunt GE
    Psychopharmacology (Berl); 2003 Aug; 168(4):465-74. PubMed ID: 12700882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.
    Welch SP; Huffman JW; Lowe J
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.
    Arévalo C; de Miguel R; Hernández-Tristán R
    Pharmacol Biochem Behav; 2001 Sep; 70(1):123-31. PubMed ID: 11566149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
    Sano K; Mishima K; Koushi E; Orito K; Egashira N; Irie K; Takasaki K; Katsurabayashi S; Iwasaki K; Uchida N; Egawa T; Kitamura Y; Nishimura R; Fujiwara M
    Neuroscience; 2008 Jan; 151(2):320-8. PubMed ID: 18083311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.
    Taffe MA
    Neuroscience; 2012 Jan; 201():125-33. PubMed ID: 22138434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats.
    Lichtman AH; Martin BR
    Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
    Mansbach RS; Rovetti CC; Winston EN; Lowe JA
    Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS; Cornish JL; Mallet PE; McGregor IS
    Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance and cross-tolerance to cannabinoids in mice: schedule-controlled responding and hypothermia.
    Singh H; Schulze DR; McMahon LR
    Psychopharmacology (Berl); 2011 Jun; 215(4):665-75. PubMed ID: 21246187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
    Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M
    Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
    Wallinga AE; Grahlmann C; Granneman RA; Koolhaas JM; Buwalda B
    Brain Res; 2011 Jun; 1398():13-20. PubMed ID: 21620380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.